H. C. Lane

1.1k total citations
15 papers, 870 citations indexed

About

H. C. Lane is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, H. C. Lane has authored 15 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Virology, 5 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in H. C. Lane's work include HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (3 papers) and HIV/AIDS drug development and treatment (3 papers). H. C. Lane is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (3 papers) and HIV/AIDS drug development and treatment (3 papers). H. C. Lane collaborates with scholars based in United States, Australia and Greece. H. C. Lane's co-authors include Henry Masur, A S Fauci, Richard T. Davey, Susan Vogel, A S Fauci, Katherine Spooner, Joseph A. Kovacs, A H Rook, T M Folks and HJ Alter and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and The Journal of Infectious Diseases.

In The Last Decade

H. C. Lane

15 papers receiving 828 citations

Peers

Countries citing papers authored by H. C. Lane

Since Specialization

Citations

This map shows the geographic impact of H. C. Lane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. C. Lane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. C. Lane more than expected).

Fields of papers citing papers by H. C. Lane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. C. Lane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. C. Lane. The network helps show where H. C. Lane may publish in the future.

Co-authorship network of co-authors of H. C. Lane

This figure shows the co-authorship network connecting the top 25 collaborators of H. C. Lane. A scholar is included among the top collaborators of H. C. Lane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. C. Lane. H. C. Lane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Accurate prediction of response to HIV therapy without a genotype: a potential tool for therapy optimization in resource-limited settings 2013 ·Antiviral Therapy ·(unknown), Andrew Revell, (unknown), Raph L Hamers, (unknown), Roos E. Barth, Annemarie M. J. Wensing, Casey D. Morrow, Robin Wood, (unknown), Peter Reiss, M Nelson, Sean Emery, Julio Montaner, H. C. Lane	1
2	Cbl and Akt regulate CXCL8-induced and CXCR1- and CXCR2-mediated chemotaxis 2006 ·International Immunology ·H. C. Lane	28
3	Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus 1996 ·New England Journal of Medicine ·Joseph A. Kovacs, Susan Vogel, Jeffrey M. Albert, Judith Falloon, Richard T. Davey, Robert Walker, Michael A. Polis, Katherine Spooner, (unknown), (unknown), G. Fyfe, H. C. Lane, Robin Dewar, Henry Masur	320
4	Immune-based therapies in HIV infection 1996 ·AIDS ·Sean Emery, H. C. Lane	17
5	Interferons in HIV and related diseases 1994 ·AIDS ·H. C. Lane	16
6	A Phase I Study of Interferon-α2b in Combination with Interleukin-2 in Patients with Human Immunodeficiency Virus Infection 1994 ·The Journal of Infectious Diseases ·Steven Schnittman, Susan Vogel, (unknown), H. C. Lane, Richard T. Davey	25
7	Isolation of HIV-1 from Plasma of Infected Individuals 1992 ·PubMed ·Robin Dewar, M Sarmiento, (unknown), Helen M. Clark, Paul E. Kennedy, (unknown), Michael Baseler, JA Metcalf, H. C. Lane, Norman P. Salzman	12
8	The role of antiretroviral therapy in living long and living well. 1990 ·PubMed ·John Zurlo, H. C. Lane	2
9	Kaposi's sarcoma of the parotid gland in acquired immunodeficiency syndrome 1989 ·Oral Surgery Oral Medicine Oral Pathology ·Chih‐Ko Yeh, Philip C. Fox, C H Fox, William D. Travis, H. C. Lane, Bruce J. Baum	30
10	Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. 1987 ·The Journal of Immunology ·A H Rook, H. C. Lane, T M Folks, (unknown), HJ Alter, A S Fauci	135
11	Effect of Combined Clofazimine and Ansamycin Therapy on Mycobacterium avium--Mycobacterium intracellulare Bacteremia in Patients with AIDS 1987 ·The Journal of Infectious Diseases ·Henry Masur, Carmelita U. Tuazon, V J Gill, (unknown), Barbara Baird, A S Fauci, H. C. Lane	95
12	Recombinant interleukin-2-induced polyclonal proliferation of in vitro unstimulated human peripheral blood lymphocytes 1986 ·Cellular Immunology ·(unknown), H. C. Lane, Anthony S. Fauci	35
13	Oligoclonal immunoglobulins in patients with the acquired immunodeficiency syndrome 1985 ·Clinical Immunology and Immunopathology ·Nicholas M. Papadopoulos, H. C. Lane, Rene Costello, Haralampos Μ. Moutsopoulos, Henry Masur, Edward P. Gelmann, Anthony S. Fauci	43
14	High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome. 1983 ·The Journal of Immunology ·H M Moutsopoulos, A D Steinberg, A S Fauci, H. C. Lane, N M Papadopoulos	67
15	Delineation of optimal conditions for producing mouse-human heterohybridomas from human peripheral blood B cells of immunized subjects. 1983 ·The Journal of Immunology ·(unknown), H. C. Lane, A S Fauci	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact